News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
157,287 Results
Type
Article (6304)
Company Profile (53)
Press Release (150930)
Multimedia
Podcasts (2)
Webinars (1)
Section
Business (53178)
Career Advice (176)
Deals (9316)
Drug Delivery (9)
Drug Development (20773)
Employer Resources (22)
FDA (3470)
Job Trends (3542)
News (84127)
Policy (6445)
Tag
Academia (517)
Accelerated approval (2)
Allergies (32)
Alliances (6894)
ALS (31)
Alzheimer's disease (427)
Antibody-drug conjugate (ADC) (49)
Approvals (3572)
Artificial intelligence (63)
Autoimmune disease (12)
Automation (5)
Bankruptcy (54)
Best Places to Work (3198)
Biosimilars (39)
Biotechnology (42)
Bladder cancer (38)
Brain cancer (10)
Breast cancer (160)
Cancer (1045)
Cardiovascular disease (85)
Career advice (153)
Career pathing (3)
CAR-T (41)
CDC (5)
Cell therapy (109)
Cervical cancer (11)
Clinical research (17717)
Collaboration (180)
Compensation (114)
Complete response letters (7)
COVID-19 (1027)
CRISPR (9)
C-suite (42)
Cystic fibrosis (37)
Data (1459)
Depression (15)
Diabetes (138)
Diagnostics (1639)
Digital health (4)
Diversity, equity & inclusion (3)
Drug discovery (39)
Drug pricing (26)
Drug shortages (3)
Duchenne muscular dystrophy (33)
Earnings (39551)
Editorial (6)
Employer branding (3)
Employer resources (21)
Events (25722)
Executive appointments (67)
FDA (4208)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (161)
Gene editing (14)
Generative AI (3)
Gene therapy (76)
GLP-1 (202)
Government (1102)
Grass and pollen (2)
Guidances (276)
Healthcare (5258)
HIV (10)
Huntington's disease (5)
IgA nephropathy (14)
Immunology and inflammation (51)
Immuno-oncology (3)
Indications (22)
Infectious disease (1077)
Inflammatory bowel disease (68)
Inflation Reduction Act (2)
Influenza (18)
Intellectual property (20)
Interviews (23)
IPO (6098)
IRA (4)
Job creations (535)
Job search strategy (132)
Kidney cancer (3)
Labor market (24)
Layoffs (84)
Leadership (2)
Legal (1001)
Liver cancer (21)
Longevity (3)
Lung cancer (176)
Lymphoma (93)
Machine learning (5)
Management (7)
Manufacturing (69)
MASH (27)
Medical device (3679)
Medtech (3683)
Mergers & acquisitions (3419)
Metabolic disorders (273)
Multiple sclerosis (51)
NASH (1)
Neurodegenerative disease (37)
Neuropsychiatric disorders (9)
Neuroscience (635)
NextGen: Class of 2025 (1137)
Non-profit (1011)
Now hiring (7)
Obesity (104)
Opinion (15)
Ovarian cancer (28)
Pain (20)
Pancreatic cancer (26)
Parkinson's disease (36)
Partnered (5)
Patents (55)
Patient recruitment (57)
Peanut (19)
People (7876)
Pharmaceutical (9)
Pharmacy benefit managers (4)
Phase I (4600)
Phase II (7608)
Phase III (7218)
Pipeline (1366)
Policy (22)
Postmarket research (682)
Preclinical (1663)
Press Release (10)
Prostate cancer (45)
Psychedelics (5)
Radiopharmaceuticals (56)
Rare diseases (126)
Real estate (740)
Recruiting (11)
Regulatory (5098)
Reports (17)
Research institute (518)
Resumes & cover letters (26)
Rett syndrome (4)
RNA editing (1)
RSV (18)
Schizophrenia (37)
Series A (20)
Series B (16)
Service/supplier (2)
Sickle cell disease (16)
Special edition (9)
Spinal muscular atrophy (48)
Sponsored (4)
Startups (510)
Stomach cancer (2)
Supply chain (11)
Tariffs (35)
The Weekly (2)
Vaccines (288)
Venture capital (12)
Weight loss (66)
Women's health (8)
Worklife (3)
Date
Today (26)
Last 7 days (169)
Last 30 days (584)
Last 365 days (8346)
2025 (6455)
2024 (9220)
2023 (10572)
2022 (11861)
2021 (32761)
2020 (12062)
2019 (9429)
2018 (6995)
2017 (6722)
2016 (5373)
2015 (7179)
2014 (4888)
2013 (3426)
2012 (3755)
2011 (4212)
2010 (3658)
Location
Africa (98)
Alabama (11)
Alaska (1)
Arizona (26)
Arkansas (1)
Asia (9491)
Australia (1294)
California (2255)
Canada (766)
China (195)
Colorado (100)
Connecticut (121)
Delaware (98)
Europe (21439)
Florida (303)
Georgia (75)
Idaho (8)
Illinois (167)
India (8)
Indiana (157)
Iowa (1)
Japan (94)
Kansas (67)
Kentucky (8)
Louisiana (7)
Maine (20)
Maryland (230)
Massachusetts (1715)
Michigan (55)
Minnesota (161)
Mississippi (1)
Missouri (21)
Montana (8)
Nevada (25)
New Hampshire (20)
New Jersey (856)
New Mexico (5)
New York (701)
North Carolina (290)
Northern California (1084)
Ohio (52)
Oregon (2)
Pennsylvania (501)
Puerto Rico (6)
Rhode Island (3)
South America (193)
South Carolina (2)
Southern California (914)
Tennessee (20)
Texas (306)
United States (8499)
Utah (71)
Virginia (33)
Washington D.C. (9)
Washington State (221)
Wisconsin (18)
157,287 Results for "23".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Regeneron Backs Off 23andMe, Losing Bid to Former CEO
Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” according to a spokesperson for the pharma.
June 16, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Invitation to Alligator Bioscience’s Earnings Call on 23 October 2025
October 16, 2025
·
1 min read
Mergers & acquisitions
Regeneron Comes to 23andMe’s Rescue With $256M Acquisition Plan
Regeneron promised to comply with 23andMe’s consumer privacy policies and related data security laws.
May 19, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Natera to Host Investor Call on October 23, 2025 to Discuss ESMO Findings
October 14, 2025
·
1 min read
Press Releases
Santhera Provides Update on Convertible Bond Issued on 23 September 2025
September 25, 2025
·
2 min read
Press Releases
Altimmune to Participate in Two Upcoming Investor Conferences - September 23, 2025
September 24, 2025
·
1 min read
Press Releases
Cellphire Therapeutics announces CRYPTICS Phase 2/3 Clinical Study Final Topline Results
October 2, 2025
·
4 min read
Press Releases
European Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency
October 6, 2025
·
11 min read
Press Releases
Celldex to Present at Morgan Stanley 23rd Annual Global Healthcare Conference
September 10, 2025
·
1 min read
Press Releases
AMGEN TO PRESENT AT THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE
September 5, 2025
·
2 min read
1 of 15,729
Next
